Vivien is the Regional Director for Asia of Novatek International. She is an accomplished Technical Sales Director, Business Development and Marketing professional with more than 25 years of experience in the information technology and services industry. She has been assisting pharmaceutical companies for the past 17 years in achieving regulatory compliance by providing technical assistance, gap analysis, computer system validation, documentation and training in the implementation and use of LIMS, digital QMS and Contamination Control solution.
Vivien served as President of the Philippines Affiliate (2017-2020) and Chair of the Asia Pacific Council (2019-2020). She is a member of several ISPE Community of Practice (COP) Steering Committees, such as the Drug Shortages Initiative Team and QC/ Analytical. She is also the current Chair of ISPE Women in Pharma® International Steering Committee and Co-Chair of ISPE GAMP South-Asia. Vivien has spoken and conducted trainings to the regulatory and industry on topics on computer system validation, data integrity and digitalization.
An ISPE campaign in 2016 piqued my interest in the Women in Pharma committee because I’m an advocate for women in the workplace. When I became President of the ISPE Philippines Affiliate in 2017, I knew that Women in Pharma...
For the past few months, ISPE Asia Pacific Affiliates and Chapters have been busy reconnecting with colleagues through in-person conferences. Collaboration, innovation, and technology are common themes; events also incorporate quality culture and excellence.
The inclusive nature of ISPE promotes diversity in thought, providing pharma professionals of all levels, geographic, and cultural backgrounds the opportunity to share their knowledge and collaborate across borders. ISPE’s...
Every year, the world rallies together on March 8th in support of International Women’s Day. This year, the movement is diving into the importance of creating a world free of bias, stereotypes, and discrimination. Below, two members of ISPE’s Women in Pharma Steering Committee share their perspective on biases, and how they navigated these experiences throughout their careers:
Innovation is generally associated with driving business outcomes and processes, adapting to technology, and developing creative management approaches. In the pharmaceutical industry, innovation takes on a more extensive and specific meaning. It is acknowledged to be continuous as it involves dynamic thinking on how to integrate technology into drug development, manufacturing processes, and...